What is OptimizeRx's EBITDA margin?

OptimizeRx (OPRX) reported EBITDA margin of 17.2% in Q1 2026.

What is the long-term trend for OptimizeRx's EBITDA margin?

Over 3 years (2021 to 2025), OptimizeRx's EBITDA margin has grown at a 57.1% compound annual growth rate (CAGR), from 3.8% to 14.7%.

What does EBITDA margin mean?

EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.

OptimizeRx OPRX EBITDA margin

EBITDA margin at other companies

Veeva SystemsVEEV

45.1%-0.2pp

PhreesiaPHR

7.7%+5.9pp

DoximityDOCS

35.6%-6.2pp

GoodRx Holdings, Inc.GDRX

20.8%+1.2pp

PubMaticPUBM

11.9%-6.8pp

Spectral AI, Inc.MDAI

-56.6%-104pp

Other financials

Income statement

See full

Revenue$19.8M-9.5%

Gross profit$14.9M+11.9%

Operating income$396.0K+119%

Net income-$495.0K+77.5%

EPS (diluted)-$0.03+75.0%

Balance sheet

See full

Cash & equivalents$20.2M+21.7%

Total debt$23.7M-27.7%

Total equity$129.6M+11.5%

Total assets$167.3M-0.3%

Cash flow

See full

Operating cash flow-$467.0K-112%

CapEx$21.0K-22.2%

Free cash flow-$488.0K-113%

Valuation

See full

Market cap$107.34M-54.1%

Enterprise value$110.88M-55.0%

P/E15.7×—

P/S1×-1.2×

Profitability

See full

Gross margin70%+14.1pp

Operating margin13.2%—

Net margin6.4%+3.6pp

FCF margin13.4%+4.8pp

Returns & leverage

See full

Return on equity5.6%+3.3pp

Debt / equity0.2×-0.1×

Current ratio5.4×+2.6×

Where this comes from

Calculated from OptimizeRx’s reported figures.

ebitda/total revenue=17.2%

Based on trailing twelve months.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's ebitda margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is OptimizeRx's EBITDA margin?: OptimizeRx (OPRX) reported EBITDA margin of 17.2% in Q1 2026.
What is the long-term trend for OptimizeRx's EBITDA margin?: Over 3 years (2021 to 2025), OptimizeRx's EBITDA margin has grown at a 57.1% compound annual growth rate (CAGR), from 3.8% to 14.7%.
What does EBITDA margin mean?: EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.